在黎巴嫩患者中治疗染色母细胞母结症的三重治疗方法

Joe Khodeir1, Paul Ohanian2, Hala Abi Rached Megarbane3

  • 1Department of Dermatology at Saint Georges Hospital University Medical Center, Faculty of Medicine and Medical Sciences University of Balamand Beirut Lebanon.

Clinical case reports
|October 2, 2024
PubMed
概括

染色母细胞菌,一种罕见的真菌性皮肤感染,需要考虑慢性病变. 结合抗真菌药物,冷治疗和5-fluorouracil的多式疗法在管理困难病例方面被证明是有效的.

相关概念视频

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
170
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K